Thymosin Beta-4 (Tβ4) is a naturally occurring, highly conserved 43-amino acid peptide present in virtually all nucleated cells of the body. TB-500, its synthetic analogue, replicates the critical active domain of this endogenous peptide. The research focus on this compound centres on its role as a primary actin-sequestering molecule and its involvement in cellular migration and tissue remodelling.
The Actin Connection
Actin is one of the most abundant proteins in eukaryotic cells and plays a fundamental structural and dynamic role. Thymosin Beta-4 binds to G-actin (globular actin) monomers, maintaining a soluble pool that can be rapidly polymerised into F-actin (filamentous actin) as needed. This regulatory function has downstream effects on cell motility, wound contraction, and angiogenesis.
Research published in journals including the Annals of the New York Academy of Sciences has explored how Tβ4 promotes the migration of keratinocytes and endothelial cells — a critical early step in wound healing. These findings have driven interest in TB-500 as a research tool for studying repair mechanisms at the cellular level.
Anti-Inflammatory Properties
Beyond its structural role, research has indicated that Tβ4 possesses anti-inflammatory properties. Studies suggest it may downregulate several pro-inflammatory cytokines, including NF-κB pathways. This dual action — promoting cellular migration while moderating inflammation — makes it a compound of considerable interest in injury response research.
Molecular Weight and Formulation
TB-500 has a molecular weight of approximately 4,963 Da, making it a medium-sized peptide. Lyophilised TB-500 for research applications should be stored at -20°C and reconstituted with bacteriostatic water immediately prior to use. Researchers should verify that their source provides HPLC purity documentation showing ≥99% purity and correct mass spectrometry confirmation of the expected molecular weight.
For in vitro research use only.